沃生物制药 VOR
$19.88 +$1.22 (+6.54%)
休市 · Nov 8, 5:10 am ET · 最新盘后价 $20.20 +1.61%
开盘$19.11
昨收$18.66
当日区间$18.62 – $20.00
成交量555.5K
市值$1.22B
市盈率（TTM）0.1
股息率–
VOR 相关新闻
匹配 Vor Biopharma 或代码 VOR 的头条新闻，按最新排序。
- Jefferies Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $48 负面
- Stifel Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $40
- Citi Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $50
- Wells Fargo Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $30
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner RA CAPITAL MANAGEMENT, L.P.
- Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $27 正面
- H.C. Wainwright Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $31
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner RA CAPITAL MANAGEMENT, L.P.
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
- HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $31 Price Target
- Vor Biopharma Price Target Maintained With a $31.00/Share by HC Wainwright & Co.
- TD Cowen Maintains Vor Biopharma(VOR.US) With Buy Rating
- Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $18 正面
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
暂无评论——快来第一个聊聊 VOR。
登录后参与讨论。